Effect of COVID-19 on Patient Access to Health Services in Latin America: A Key Informant Survey

Abstract BackgroundCOVID-19 has been felt acutely in Latin America with several countries having among the highest numbers of COVID-19 cases and deaths. The purpose of this study was to assess the effects of COVID-19 on access to health services in Latin America, as reported by patient advocacy organizations representing autoimmune, chronic, and noncommunicable diseases.MethodsIn August 2020, we conducted an online key informant survey in Spanish and Portuguese among patient advocacy organizations in 18 countries in Latin America. Univariate and bivariate analysis was conducted across two main subject areas: perceived patient effects from COVID-19 and patient access to health services. The main outcomes of analysis considered patient access to care during COVID-19 based on type of chronic illness and geographical region in Latin America.ResultsA total of 81 survey responses were analyzed. A majority (83%) of patient advocacy organizations reported their patients experienced delays receiving their treatment and care services; 52% experienced delays of 30 days or more. Telemedicine was considered available, but not accessible to patients (37%) and a majority (76%) of patients faced challenges with electronic prescriptions. Patients were not likely to receive a multi-month prescription from their doctor (38%) or successfully fill it at the pharmacy (26%).ConclusionsPeople living with noncommunicable diseases in Latin America have been seriously impacted by the COVID-19 pandemic. As countries re-evaluate their health systems, it is critical that chronic diseases are considered so that all can fully realize the right to health.